Hester Biosciences Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Hester Biosciences.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Biotechs earnings growth	38.2%
Revenue growth rate	n/a
Future return on equity	n/a
Analyst coverage	None
Last updated	n/a

Recent future growth updates

Recent updates

Revenues Working Against Hester Biosciences Limited's (NSE:HESTERBIO) Share Price

Jun 12

Hester Biosciences (NSE:HESTERBIO) Has Announced A Dividend Of ₹10.00

Aug 01

Would Hester Biosciences Limited (NSE:HESTERBIO) Be Valuable To Income Investors?

Mar 03

Did You Miss Hester Biosciences' (NSE:HESTERBIO) Whopping 308% Share Price Gain?

Feb 13

What Is The Ownership Structure Like For Hester Biosciences Limited (NSE:HESTERBIO)?

Jan 26

Who Has Been Buying Hester Biosciences Limited (NSE:HESTERBIO) Shares?

Jan 11

Hester Biosciences Limited's (NSE:HESTERBIO) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Dec 25

Are Hester Biosciences's (NSE:HESTERBIO) Statutory Earnings A Good Guide To Its Underlying Profitability?

Dec 10

These 4 Measures Indicate That Hester Biosciences (NSE:HESTERBIO) Is Using Debt Extensively

Nov 25

How Does Hester Biosciences Limited (NSE:HESTERBIO) Fare As A Dividend Stock?

Nov 10

If You Had Bought Hester Biosciences (NSE:HESTERBIO) Shares Five Years Ago You'd Have Earned 212% Returns

Oct 26

What Type Of Shareholders Own The Most Number of Hester Biosciences Limited (NSE:HESTERBIO) Shares?

Oct 05

Are Strong Financial Prospects The Force That Is Driving The Momentum In Hester Biosciences Limited's NSE:HESTERBIO) Stock?

Sep 14

These 4 Measures Indicate That Hester Biosciences (NSE:HESTERBIO) Is Using Debt Extensively

Aug 25

How Much Are Hester Biosciences Limited (NSE:HESTERBIO) Insiders Taking Off The Table?

Aug 07

Hester Biosciences Limited (NSE:HESTERBIO) Is Yielding 0.5% - But Is It A Buy?

Jul 07

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Hester Biosciences has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

NSEI:HESTERBIO - Analysts future estimates and past financials data (INR Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
3/31/2024	3,152	189	237	481	N/A
12/31/2023	2,992	185	N/A	N/A	N/A
9/30/2023	3,106	257	-52	228	N/A
6/30/2023	3,164	285	N/A	N/A	N/A
3/31/2023	2,782	266	-542	236	N/A
12/31/2022	2,723	298	N/A	N/A	N/A
9/30/2022	2,514	271	-1,404	52	N/A
6/30/2022	2,379	308	N/A	N/A	N/A
3/31/2022	2,466	393	-870	87	N/A
12/31/2021	2,504	413	N/A	N/A	N/A
9/30/2021	2,501	451	219	357	N/A
6/30/2021	2,397	412	N/A	N/A	N/A
3/31/2021	2,177	344	173	581	N/A
12/31/2020	1,989	275	N/A	N/A	N/A
9/30/2020	1,917	267	-385	408	N/A
6/30/2020	1,848	265	N/A	N/A	N/A
3/31/2020	1,878	292	-367	368	N/A
12/31/2019	1,956	396	N/A	N/A	N/A
9/30/2019	1,906	409	128	598	N/A
6/30/2019	1,890	413	N/A	N/A	N/A
3/31/2019	1,842	416	241	467	N/A
3/31/2018	1,373	256	151	380	N/A
3/31/2017	1,232	235	N/A	348	N/A
3/31/2016	1,009	192	N/A	188	N/A
3/31/2015	900	136	N/A	198	N/A
3/31/2014	690	95	N/A	94	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if HESTERBIO's forecast earnings growth is above the savings rate (6.7%).

Earnings vs Market: Insufficient data to determine if HESTERBIO's earnings are forecast to grow faster than the Indian market

High Growth Earnings: Insufficient data to determine if HESTERBIO's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if HESTERBIO's revenue is forecast to grow faster than the Indian market.

High Growth Revenue: Insufficient data to determine if HESTERBIO's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if HESTERBIO's Return on Equity is forecast to be high in 3 years time

Hester Biosciences Future Growth

Future criteria checks 0/6

Key information

Recent future growth updates

Price target decreased to ₹2,015

Price target increased to ₹2,780

Recent updates

Revenues Working Against Hester Biosciences Limited's (NSE:HESTERBIO) Share Price

Full year 2024 earnings released: EPS: ₹24.88 (vs ₹31.30 in FY 2023)

Hester Biosciences Limited Proposes Dividend for the Financial Year 2023- 24

Hester Biosciences Limited to Report Q4, 2024 Results on May 10, 2024

Investor sentiment improves as stock rises 19%

Hester Biosciences Limited Announces Executive Changes

Third quarter 2024 earnings released: EPS: ₹4.73 (vs ₹14.29 in 3Q 2023)

Second quarter 2024 earnings released: EPS: ₹4.75 (vs ₹7.77 in 2Q 2023)

Upcoming dividend of ₹8.00 per share at 0.5% yield

Hester Biosciences Limited to Report Q2, 2024 Results on Nov 14, 2023

Hester Biosciences Limited Recommends Dividend for the Financial Year 2022-23, Dividend Payment Date on or After Monday, 25 September 2023

First quarter 2024 earnings released: EPS: ₹7.89 (vs ₹4.19 in 1Q 2023)

Hester Biosciences Limited to Report Q1, 2024 Results on Aug 08, 2023

Hester Biosciences Limited Recommends Dividend for the Financial Year 2022-23

Full year 2023 earnings: EPS misses analyst expectations

Investor sentiment improves as stock rises 16%

Now 20% undervalued after recent price drop

Hester Biosciences Limited to Report Q3, 2023 Results on Jan 31, 2023

Now 20% undervalued after recent price drop

Price target decreased to ₹2,015

Second quarter 2023 earnings released: EPS: ₹7.77 (vs ₹13.08 in 2Q 2022)

Hester Biosciences Limited to Report Q2, 2023 Results on Nov 04, 2022

Now 26% undervalued

Now 22% undervalued after recent price drop

Upcoming dividend of ₹10.00 per share

Full year 2022 earnings: EPS and revenues miss analyst expectations

Hester Biosciences Limited to Report Q1, 2023 Results on Aug 10, 2022

Hester Biosciences (NSE:HESTERBIO) Has Announced A Dividend Of ₹10.00

Hester Biosciences Limited, Annual General Meeting, Aug 23, 2022

Hester Biosciences Limited Efforts to Combat the Current Outbreak of Lumpy Skin Disease in Gujarat and Certain Other Parts of India

Now 21% undervalued after recent price drop

Hester Biosciences Limited Recommends Dividend for the Financial Year 2021-22

Full year 2022 earnings: EPS and revenues miss analyst expectations

Price target increased to ₹2,780

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Second quarter 2022 earnings released: EPS ₹13.08 (vs ₹7.86 in 2Q 2021)

Upcoming dividend of ₹10.00 per share

Full year 2021 earnings released: EPS ₹40.47 (vs ₹34.29 in FY 2020)

Chief Financial Officer Chetas Patel has left the company

Full year 2021 earnings released: EPS ₹40.79 (vs ₹34.29 in FY 2020)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Would Hester Biosciences Limited (NSE:HESTERBIO) Be Valuable To Income Investors?

Did You Miss Hester Biosciences' (NSE:HESTERBIO) Whopping 308% Share Price Gain?

Third quarter 2021 earnings released: EPS ₹15.13 (vs ₹14.05 in 3Q 2020)

What Is The Ownership Structure Like For Hester Biosciences Limited (NSE:HESTERBIO)?

New 90-day low: ₹1,655

Hester Biosciences Limited to Report Q3, 2021 Results on Jan 30, 2021

Who Has Been Buying Hester Biosciences Limited (NSE:HESTERBIO) Shares?

Hester Biosciences Limited's (NSE:HESTERBIO) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

New 90-day low: ₹1,683

Are Hester Biosciences's (NSE:HESTERBIO) Statutory Earnings A Good Guide To Its Underlying Profitability?

These 4 Measures Indicate That Hester Biosciences (NSE:HESTERBIO) Is Using Debt Extensively

How Does Hester Biosciences Limited (NSE:HESTERBIO) Fare As A Dividend Stock?

First half earnings released

If You Had Bought Hester Biosciences (NSE:HESTERBIO) Shares Five Years Ago You'd Have Earned 212% Returns

New 90-day high: ₹1,850

What Type Of Shareholders Own The Most Number of Hester Biosciences Limited (NSE:HESTERBIO) Shares?

New 90-day high: ₹1,753

Are Strong Financial Prospects The Force That Is Driving The Momentum In Hester Biosciences Limited's NSE:HESTERBIO) Stock?

These 4 Measures Indicate That Hester Biosciences (NSE:HESTERBIO) Is Using Debt Extensively

New 90-day high - ₹1,558

Upcoming Dividend of ₹6.60 Per Share

How Much Are Hester Biosciences Limited (NSE:HESTERBIO) Insiders Taking Off The Table?

New 90-day high - ₹1,348

Hester Biosciences Limited (NSE:HESTERBIO) Is Yielding 0.5% - But Is It A Buy?

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies